Table 2.
Radiodensity values of osteosclerotic lesions in MRONJ patients
| Variables | N (%) | Radiodensity values (mean ± SD) | P values |
|---|---|---|---|
| Bisphosphonates duration | 25 (100) | 896.25±162.06 | 0.040*# |
| Age | 25 (100) | 896.25±162.06 | 0.511# |
| Gender | |||
| Male | 13 (58.0) | 856.11±179.56 | 0.276 |
| Female | 12 (52.0) | 947.86±130.96 | |
| Routes | NA | ||
| Oral | 1 (4.00) | 753.53 | |
| IV | 24 (96.0) | 905.80±163.02 | |
| Location | 0.367 | ||
| Maxilla | 8 (32.0) | 830.50±226.035 | |
| Mandible | 17 (68.0) | 918.17±140.66 | |
| Osteoporosis | 0.403 | ||
| No | 20 (80.0) | 909.57±168.50 | |
| Yes | 5 (20.0) | 803.00±70.711 | |
| Chemotherapy | 0.777 | ||
| No | 13 (52.0) | 908.22±88.630 | |
| Yes | 12 (48.0) | 880.86±233.87 | |
| Targeted drugs | 0.888 | ||
| No | 16 (64.0) | 891.60±169.37 | |
| Yes | 9 (36.0) | 904.00±164.44 | |
| Immune suppressive drugs | 0.598 | ||
| No | 22 (88.0) | 904.71±172.19 | |
| Yes | 3 (22.0) | 837.00±22.627 |
Notes: #P values were calculated by liner regression. *P values were statistically significant.